| Miss Kimberly Middleton, PT | |
|
671 Grants Ferry Rd Ste A, Flowood, MS 39232-6801 | |
| (769) 777-4400 | |
| (769) 777-4401 |
| Full Name | Miss Kimberly Middleton |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 671 Grants Ferry Rd Ste A, Flowood, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376782268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT2002 (Mississippi) | Primary |
| Provider Name | Reliant, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1013213594 PECOS PAC ID: 3476737834 Enrollment ID: O20110408000219 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
Diagnostic agreement between practitioners is an ongoing challenge in the evaluation of Traditional Chinese Medicine and other healthcare systems that rely on constitutional types.
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
› Verified 2 days ago
| Provider Name | Xcel Rehab, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1003273897 PECOS PAC ID: 7618272519 Enrollment ID: O20160301000874 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
Diagnostic agreement between practitioners is an ongoing challenge in the evaluation of Traditional Chinese Medicine and other healthcare systems that rely on constitutional types.
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
› Verified 2 days ago
| Provider Name | Motions Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1750935953 PECOS PAC ID: 7618208778 Enrollment ID: O20191004000483 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
Diagnostic agreement between practitioners is an ongoing challenge in the evaluation of Traditional Chinese Medicine and other healthcare systems that rely on constitutional types.
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Kimberly Middleton, PT 3825 Highway 80 E, Pearl, MS 39208-4232 Ph: (769) 777-4400 | Miss Kimberly Middleton, PT 671 Grants Ferry Rd Ste A, Flowood, MS 39232-6801 Ph: (769) 777-4400 |
News Archive
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.
Diagnostic agreement between practitioners is an ongoing challenge in the evaluation of Traditional Chinese Medicine and other healthcare systems that rely on constitutional types.
Low dose Aspirin has been advocated to reduce the risk of a second heart attack or a stroke or other heart problems in persons who have had one episode. A major new study published in the Lancet, has found that taking Aspirin to prevent the first heart attack fails to work. In fact the risks of taking low dose Aspirin to prevent the first heart attack outweigh the benefits.
› Verified 2 days ago
Connie W Moore, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 533b Keyway Dr, Flowood, MS 39232 Phone: 601-420-0717 | |
Peter E Schott, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2470 Flowood Dr, Flowood, MS 39232 Phone: 877-554-4257 Fax: 601-983-2839 | |
Champion Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 901 Lakeland Pl Ste 9, Flowood, MS 39232 Phone: 769-251-1148 Fax: 769-216-2156 | |
Genesis Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 290 E Layfair Dr, Suite B, Flowood, MS 39232 Phone: 601-983-1200 Fax: 601-983-1205 | |
Specialized Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 533b Keyway Dr, Flowood, MS 39232 Phone: 601-420-0717 Fax: 601-420-0957 | |
Lindsey F Byrd, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2470 Flowood Dr, Flowood, MS 39232 Phone: 877-554-4257 | |
Mark F Ware, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4435 Mangum Dr, Suite A, Flowood, MS 39232 Phone: 601-932-0305 |